RU2002121546A - SUBSTANCES FOR THE TREATMENT OF PSORIASIS - Google Patents

SUBSTANCES FOR THE TREATMENT OF PSORIASIS

Info

Publication number
RU2002121546A
RU2002121546A RU2002121546/15A RU2002121546A RU2002121546A RU 2002121546 A RU2002121546 A RU 2002121546A RU 2002121546/15 A RU2002121546/15 A RU 2002121546/15A RU 2002121546 A RU2002121546 A RU 2002121546A RU 2002121546 A RU2002121546 A RU 2002121546A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
psoriasis
diacerein
treatment
pharmaceutically acceptable
Prior art date
Application number
RU2002121546/15A
Other languages
Russian (ru)
Other versions
RU2266740C2 (en
Inventor
НАПОЛИ Гвидо ДИ
Original Assignee
Лаборатуар Медидом С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Медидом С.А. filed Critical Лаборатуар Медидом С.А.
Publication of RU2002121546A publication Critical patent/RU2002121546A/en
Application granted granted Critical
Publication of RU2266740C2 publication Critical patent/RU2266740C2/en

Links

Claims (12)

1. Применение диацереина или его фармацевтически приемлемого производного для получения фармацевтической композиции для лечения псориаза и связанных с ним заболеваний.1. The use of diacerein or its pharmaceutically acceptable derivative to obtain a pharmaceutical composition for the treatment of psoriasis and related diseases. 2. Применение диацереина или его фармацевтически приемлемого производного для получения фармацевтической композиции для лечения псориаза.2. The use of diacerein or its pharmaceutically acceptable derivative to obtain a pharmaceutical composition for the treatment of psoriasis. 3. Применение диацереина или его фармацевтически приемлемого производного для получения фармацевтической композиции для лечения псориаза и псориатического артрита.3. The use of diacerein or its pharmaceutically acceptable derivative to obtain a pharmaceutical composition for the treatment of psoriasis and psoriatic arthritis. 4. Применение диацереина для получения фармацевтической композиции для лечения псориаза.4. The use of diacerein to obtain a pharmaceutical composition for the treatment of psoriasis. 5. Применение диацереина для получения фармацевтической композиции для лечения псориаза и псориатического артрита.5. The use of diacerein to obtain a pharmaceutical composition for the treatment of psoriasis and psoriatic arthritis. 6. Применение по любому из пп.1-5, в котором фармацевтическая композиция находится в форме, подходящей для приема внутрь.6. The use according to any one of claims 1 to 5, in which the pharmaceutical composition is in a form suitable for oral administration. 7. Применение по п.6, в котором фармацевтическая композиция дозирована таким образом, что это соответствует ежедневному приему внутрь 30-200 мг диацереина.7. The use according to claim 6, in which the pharmaceutical composition is dosed so that it corresponds to a daily oral administration of 30-200 mg of diacerein. 8. Применение по п.6, в котором дозировка равна 100 мг в день по меньшей мере в два приема.8. The use according to claim 6, in which the dosage is 100 mg per day in at least two doses. 9. Применение по любому из пп.1-5, в котором фармацевтическая композиция находится в форме крема или мази для местного нанесения на те части кожных покровов, что поражены псориазом.9. The use according to any one of claims 1 to 5, in which the pharmaceutical composition is in the form of a cream or ointment for topical application to those parts of the skin that are affected by psoriasis. 10. Способ лечения псориаза, включающий введение фармацевтической композиции, содержащей эффективное количество диацереина или его фармацевтически приемлемого производного.10. A method of treating psoriasis, comprising administering a pharmaceutical composition comprising an effective amount of diacerein or a pharmaceutically acceptable derivative thereof. 11. Способ лечения псориаза и псориатического артрита, включающий введение фармацевтической композиции, содержащей эффективное количество диацереина или его фармацевтически приемлемого производного.11. A method of treating psoriasis and psoriatic arthritis, comprising administering a pharmaceutical composition comprising an effective amount of diacerein or a pharmaceutically acceptable derivative thereof. 12. Способ по п.10 или 11, в котором фармацевтическая композиция находится в форме, подходящей для приема внутрь.12. The method according to claim 10 or 11, in which the pharmaceutical composition is in a form suitable for oral administration.
RU2002121546/15A 2000-01-12 2001-01-08 Substances usable for treating psoriasis cases RU2266740C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH0053/00 2000-01-12
CH532000 2000-01-12

Publications (2)

Publication Number Publication Date
RU2002121546A true RU2002121546A (en) 2004-04-10
RU2266740C2 RU2266740C2 (en) 2005-12-27

Family

ID=4291590

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002121546/15A RU2266740C2 (en) 2000-01-12 2001-01-08 Substances usable for treating psoriasis cases

Country Status (22)

Country Link
US (2) US6844365B2 (en)
EP (1) EP1248608B1 (en)
JP (1) JP4912554B2 (en)
CN (1) CN1187045C (en)
AR (1) AR026801A1 (en)
AT (1) ATE254913T1 (en)
AU (1) AU776324B2 (en)
BR (2) BR0107493A (en)
CA (1) CA2396111C (en)
CZ (1) CZ301129B6 (en)
DE (1) DE60101309T2 (en)
DK (1) DK1248608T3 (en)
ES (1) ES2210120T3 (en)
IL (2) IL150390A0 (en)
MX (1) MXPA02006610A (en)
PL (1) PL212010B1 (en)
PT (1) PT1248608E (en)
RU (1) RU2266740C2 (en)
SK (1) SK286589B6 (en)
TR (1) TR200400228T4 (en)
WO (1) WO2001051044A2 (en)
ZA (1) ZA200205148B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (en) * 2002-12-30 2007-06-20 北京大学第一医院 Use of chrysophanic acid in inhibiting vascularization
CN101500607B (en) 2005-05-16 2013-11-27 阿布维生物技术有限公司 Use of TNFalpha inhibitor for treatment of erosive polyarthritis
WO2008063213A2 (en) * 2006-04-10 2008-05-29 Abbott Biotechnology Ltd. Uses and compositions for treatment of psoriatic arthritis
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (en) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 Diacerein composition with good leaching property, and preparation and use thereof
AU2011237600B2 (en) * 2010-04-08 2016-06-23 Twi Biotechnology, Inc. Methods of using diacerein as an adjunctive therapy for diabetes
US20180311199A1 (en) * 2016-01-12 2018-11-01 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (en) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 A kind of diacerein capsule preparations and preparation method thereof
CN106692109A (en) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 Microporous membrane-coated controlled-release diacerein pellet and preparation method thereof
JP2020505362A (en) * 2017-01-19 2020-02-20 ティダブリューアイ・バイオテクノロジー・インコーポレイテッドＴＷＩ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． Methods and pharmaceutical compositions for preventing or treating immunoinflammatory skin disorders
CN106667954A (en) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 Diacerein soft capsule preparation and preparation process thereof
CN106619555A (en) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 Diacerein quick-release pellet preparation and preparation method
CN106727360A (en) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 A kind of diacerein solid dispersion preparation and preparation method thereof
AU2019245521A1 (en) * 2018-03-29 2020-11-12 S.I.S Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (en) * 2021-02-22 2021-05-07 北京市中医研究所 Pharmaceutical application of rhein serving as inhibitor of S100A8 in inflammatory diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (en) * 1986-10-01 1988-11-30 Proter Spa GALENIC FORMULATION FOR ORAL USE OF REINA DERIVATIVES SLOWLY RELEASED FOR THERAPEUTIC USE
IT1264545B1 (en) 1993-07-30 1996-10-02 Medidom Lab PROCEDURE FOR THE PREPARATION OF DIACEREIN
IT1282381B1 (en) 1996-04-29 1998-03-20 Trans Bussan S A NEW FORMULATIONS OF DIACEREIN, OBTAINED BY INCLUSION OF THE ACTIVE INGREDIENT IN HYDROGEL POLYSACCHARIDES
IT1283772B1 (en) 1996-07-31 1998-04-30 Medidom Lab PROCEDURE FOR THE REINA AND DIACEREIN PREPARATION
IT1283771B1 (en) 1996-07-31 1998-04-30 Medidom Lab PROCEDURE FOR THE PREPARATION OF REINA DERIVATIVES
JP4049406B2 (en) * 1996-10-15 2008-02-20 正規 小菅 Tsu fluid improving agent and composition for oral administration containing the same
JP4018764B2 (en) * 1996-10-18 2007-12-05 正規 小菅 Skin preparation for improving tsunami
JPH10129556A (en) 1996-10-28 1998-05-19 Fumiaki Mori Burglarproof bicycle
FR2757397B1 (en) * 1996-12-23 1999-03-05 Mazal Pharma PHARMACEUTICAL COMPOSITION BASED ON RHEIN OR DIACERHEIN WITH IMPROVED BIOAVAILABILITY
IT1297038B1 (en) 1997-12-30 1999-08-03 Medidom Lab PROCEDURE FOR THE PREPARATION OF REINA AND ITS DIACYLIVERS

Similar Documents

Publication Publication Date Title
RU2002121546A (en) SUBSTANCES FOR THE TREATMENT OF PSORIASIS
EP1444984B1 (en) Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes
ATE283048T1 (en) COMPOSITIONS CONTAINING CYCLOOXYGENASE-2 INHIBITORS WITH A RAPID ONSET OF ACTION
JPS58210026A (en) Drug administration penetration promotor by whole body medicine skin penetration
HK1071847A1 (en) Dosage forms having prolonged active ingredient release
RU2007101538A (en) APPLICATION OF PHARMACEUTICAL COMPOSITION CONTAINING CALCITRIOL AND CLOBETASOL PROPIONATE FOR THE TREATMENT OF PSORIASIS
WO1999040883A3 (en) Compositions and methods for the treatment of cystic fibrosis
KR20100126367A (en) Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
KR960000855A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
AR035946A1 (en) PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES
US5036100A (en) Pharmaceutical method and preparation containing indomethacin
JP2002540148A5 (en)
US5716646A (en) Methods and compositions for treating arthritis
RU2002129298A (en) APPLICATION OF GALANTAMINE FOR THE TREATMENT OF PSYCHONEUROLOGICAL BEHAVIOR ASSOCIATED WITH ALZHEIMER'S DISEASE
JPH08505402A (en) Method for treating mucosal epidermal and epidermal pain, inflammation and infectious disease and therapeutic composition
DE3688787D1 (en) PRODUCTION OF A MEDICINE AGAINST ARTHRITIS AND RHEUMATISM.
ATE275953T1 (en) 2,3 DIARYL-1-BENZOPYRAMES FOR THE TREATMENT OF DERMATITIS
Rida et al. Case report of refractory psoriatic arthritis achieving remission using Nigella sativa (black seed oil) extract
JP2003523920A5 (en)
EA200300430A1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING EPINASTINES AND PSEVDOEDFEDRIN
JP2752250B2 (en) Basic therapeutic agent with analgesic and anti-inflammatory action
KR830008678A (en) Analgesic composition
JPS6187621A (en) Remedy for allergic rhinitis and allergic asthma